• There are no suggestions because the search field is empty.

SaMD versus MDSW: what’s the difference between Software as a Medical Device and Medical Device SoftWare?

Author Avatar
Anne-Sophie Grell, RA Manager MD at QbD Group
Regulatory Affairs
Medical Devices
The terms SaMD (Software as a Medical Device) and MDSW (Medical Device SoftWare) are often used interchangeably within medical environments, but they are not. Learn the difference in meaning and regulatory scope here.
SaMD versus MDSW: what’s the difference between Software as a Medical Device and Medical Device SoftWare? | QbD Group
7:23

Nowadays, digital healthcare is taking an increasingly important place in the medical world through medical software, image processing, diagnostic support, home monitoring, etc… but all software used in a medical environment is not necessarily subject to medical regulations. Even the definition/designation of Software as a Medical Device (SaMD) can vary from country to country.

The International Medical Device Regulators Forum (IMDRF) has published guidance on Software as a Medical Device (SaMD) and what is related to it (more on that below), but it is important to realize that this guidance is not binding and thus not really followed by all countries.

In Europe, for example, the name is different: “MDSW” or “Medical Device software“. MDSW covers a different scope for software in the medical field than recommended in the IMDRF guidelines. Confused? No worries. This article will help you list the main differences between SaMD and MDSW so that you can set up a registration strategy.

 

SaMD: different meanings and levels of regulation

Different meanings: IMDRF as a (mere) guideline

The International Medical Device Regulators Forum (IMDRF), established in February 2011, is a forum that consists of voluntary medical device regulators from around the world who have come together to build on the strong foundational work of the Global Harmonization Task Force on Medical Devices (GHTF) and to accelerate international harmonization and convergence of medical device regulations.

Recently, the IMDRF published guidelines for “Software as a Medical Device (SaMD)” (available at imdrf.org). These guidelines are not binding. Countries that do not yet have regulations for medical software usually adopt the IMDRF’s recommendations, but a lot of countries have already adopted their own regulations.

As mentioned, the EU already defined MDSW into the MDR, for example. Consequently, most regulatory agencies have assigned a different meaning to SaMD. Often this meaning also depends on whether SaMD is built into the medical device or not.

 

Different levels of regulation around the world

On top of that, the level of software regulation in different countries is also quite different:

  • The EU and Australia regulate a very large scope related to software;
  • Most South American countries, India, China, Japan, and a few others have an average scope;
  • Russia, Canada, and the US regulate software to a lesser extent than all the previous countries;
  • and the rest of the world has no regulation of software at all. (See figure below)
As a result, your software may be considered a medical device in Europe and not at all in the US or elsewhere in the world. It is therefore important to know where the software will be commercialized in order to comply with the appropriate regulations. 
 
SaMD versus MDSW - what’s the difference between Software as a Medical Device and Medical Device SoftWare

Figure 1 – Software as Medical Device- Regulatory and Market Access Implication by Koen Cobbaert & Gert Bos

 

SaMD versus MDSW: definitions

 

When it comes to software within medical environments, the terms SaMD and MDSW are often used interchangeably, but in fact, they are not.

Even if there are some similarities, they do not cover the same scope of software used in the medical field.

If you only do business in Europe, the only definition and relevant regulation you need to take care of is ‘MDSW’ regulated by the MDR, but if you’re not, it’s important to look at SaMD as well.

Below, you can find both definitions:

What is SaMD?

The IMDRF defines ‘Software as a Medical Device’ or ‘SaMD’ as

“Software intended to be used for one or more medical purposes that perform the purposes without being part of a hardware medical Device. Software is a SaMD regardless of the fact that it needs Hardware to execute. Regardless of whether it operates on general-purpose IT equipment, in “the cloud” or on the computing platform of a HW of a Medical device, as long as it is not “necessary for the HW medical device to achieve its Intended medical purpose.”

 

What is MDSW?

The term Medical Device Software or ‘MDSW’ is only used in the EU. (SaMD is not used in the EU). Medical Device Software for classification purposes is defined in MDR rule 11.

That rule applies to software-only devices AND hardware devices that comprise MDSW as an integral part.

The MDCG has also defined MDSW as such and provided more guidance on how to understand the MDR for software.

 

How are SaMD and MDSW alike and how do they differ?

 

As you can see, SaMD and MDSW are similar, but not synonyms. Below, we’ve listed important commonalities and differences:

What do SaMD and MDSW have in common?

  • Both SaMD and MDSW fulfill one or more medical purposes independently, meaning that the software is not used to control a medical device but has its own medical purpose.
    • For example, consider treatment planning that uses images from various imaging devices to calculate a treatment for a patient.
  • Both apply to software operating on general-purpose computing platforms, as well as to software running on platforms that are part of a hardware medical device.
    • By “general-purpose computing platform”, we mean any computer used to make that software running to analyze some X-ray images, for example, and that it is not the actual computer where the images are acquired.
    • By “software running on platforms that are part of the medical device”, we mean additional software installed on the computer, used to acquire X-ray images, for example.

Are these commonalities important? They might be! If you want to register your software both in the US and in the EU, for example, it may be interesting to find out whether your software complies with both regulations (definitions).

 

 What are the differences between SaMD and MDSW?

  • MDSW also applies to software that fulfills a medical device purpose on its own but is at the same time necessary for a medical device to achieve its medical purpose (SaMD). Some examples:
    • An insulin dose calculator that is also necessary to drive the infusion pump (can be an MDSW but not a SaMD).
    • The software embedded in a thermometer is considered a medical device by the IMDRF and MDR, but, in the US, this does not hold.
  • MDSW – due to the MDR definition of a medical device – also includes any software “supporting conception” and “alleviation of a disability”.

  • MDSW does not include software that solely is intended to drive or influence the use of medical devices. E.g.:
    • Software for obtaining X-ray images is used solely by the X-ray hardware, such as a mammograph or a CT scanner.

  • SaMD at the international level includes software to aggregate information for medical purposes which is NOT regulated in the EU. In other words, all software treating medical information in the hospital is not considered as a medical device in Europe but is in some other countries.



Conclusion: check all regulations

 

In conclusion, if you want to launch your software on the market as a medical device, it is important to check all regulations as there are a lot of differences.

Our experts can help you

  • determine whether or not your software is a medical device,

  • check how it is regulated in the markets you want to enter,

  • and determine your regulatory pathway/strategy for bringing your software to market.

 

 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Discover more expert content

preview_image
Case study

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader​

QbD Group streamlines linguistic reviews for a leading pharma client, ensuring compliance and accuracy across 25 EU/EEA languages while meeting stringent regulatory deadlines.
preview_image
Whitepaper

Medical Device Regulation (MDR) Checklist

Implement the Medical Device Regulation (MDR) with ease. Download our checklist of mandatory documents for MDR compliance.
preview_image
Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
preview_image
Webinar

Drug-Device Combination Products and Article 117

Explore the regulatory complexities of Drug-Device Combination Products. Learn about Article 117 requirements, Notified Body Opinions, and more.
preview_image
Whitepaper

Mobile health on the rise: exploring the regulatory landscape for reimbursement

This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.
preview_image
Whitepaper

Clinical investigations under MDR: key insights and practical experiences

This whitepaper covers clinical investigation authorization under MDR, the EU Legal Representative's role, and the MDR's impact on study conduct and post-market surveillance.
preview_image
Case study

CE Mark Renewal for bioXtra Products: A Success Story

Discover how Lifestream Pharma successfully renewed the CE mark for their BioXtra Dry Mouth products under the EU MDR. Learn about the challenges faced, the approach taken for compliance, and the results achieved.
preview_image
Webinar

Technical Documentation Essentials for Medical Device Software

Gain practical insights on crafting MDR-compliant technical documentation for Medical Device Software.
preview_image
Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.
preview_image
Webinar

Mastering Clinical Performance Studies under IVDR

In the evolving regulatory landscape of IVDs, demonstrating clinical performance is more crucial and challenging than ever. Discover more in this webinar on demand.
preview_image
Whitepaper

Clinical evidence for In Vitro Diagnostics under IVDR

In this whitepaper, we will guide you through the documents required for the demonstration of clinical evidence under the IVDR. Download now.
preview_image
Webinar

Post-Market Surveillance Requirements for Medical Devices and IVDs

Learn about post-market surveillance requirements under MDR and IVDR regulations. Gain insights from industry experts in this on-demand webinar.
preview_image
Whitepaper

The key role of Regulatory Affairs in the pharmaceutical industry: from drug development to commercialization

Discover the key role of Regulatory Affairs in pharma and how Regulatory Affairs teams support product lifecycle management in this whitepaper. Download now.
preview_image
Webinar

3D Printing in the Healthcare World

Explore the challenges and opportunities of 3D printing in healthcare, featuring expert insights on regulations, pitfalls, and efficiency.
preview_image
Webinar

IVDR Extension Explained: Tips & Strategies

Gain valuable insights on the IVDR extension and its impact on IVD manufacturers with our webinar on demand.
preview_image
Whitepaper

Innovations in ATMP: state of the industry in 2024

This whitepaper explores the innovations in ATMP and solutions in detail, with a focus on the current landscape as of April 2024. Download now.
preview_image
Case study

The journey toward IVDR compliance for the LVOne device

QbD Group helped Upfront Diagnostics gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.
preview_image
Case study

Ensuring a smooth MDR transition for Oystershell's medical devices

The landscape of medical device regulations is constantly evolving, making it a challenge for companies to keep up. Our collaboration with Oystershell, which began in July 2023, highlights our expertise in transforming complex challenges into success stories, all with a touch of QbD Clinical magic.
preview_image
Case study

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

QbD Clinical assisted Minze Health, a urology-focused medical devices company, in obtaining CE marking under MDR through clinical evaluation.
preview_image
Webinar

The Medical Device CE Certification Pathway Explained: From Classification to Conformity Assessment by the Notified Body

Learn about the Medical Device CE Certification Pathway, from classification to conformity assessment by a Notified Body. Join our webinar on demand.
preview_image
Case study

Helping Relu to comply with changing regulations

QbD Group supported software company Relu with their expertise to comply with changing regulations.
preview_image
Case study

Quickly bringing a new COVID-19 medical device to market

Obtaining the required government certifications for a medical device is always a challenge. Especially when the COVID clock is ticking.